Related Experiment Video

Updated: Oct 3, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 26, 2009

Beta2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of

L Vallar1, V Regnault, V Latger-Cannard

  • 1Laboratoire Franco-Luxembourgeois de Recherche Biomédicale (CNRS and CRP-Santé), Center Universitaire, Luxembourg.

Thrombosis and Haemostasis
|March 15, 2001
PubMed

Insights

Beta2-glycoprotein I (beta2GPI) binds to platelet-derived microparticles (PMP), potentially modulating their functions. This binding specifically affects GPIIb/IIIa immunoreactivity, suggesting a regulatory role for beta2GPI in platelet-related processes.

Area of Science:

  • Immunology
  • Hematology
  • Biochemistry

Background:

  • Platelet-derived microparticles (PMP) are released from activated platelets and carry surface proteins.
  • Beta2-glycoprotein I (beta2GPI) is an autoantigen implicated in autoimmune diseases.
  • The interaction between beta2GPI and PMP, and its functional consequences, require further investigation.

Purpose of the Study:

  • To investigate the binding of beta2GPI to PMP.
  • To determine the effect of beta2GPI binding on the immunoreactivity of GPIIb/IIIa on PMP.
  • To explore the potential functional modulation of PMP by beta2GPI.

Main Methods:

  • Isolation of PMP from human platelets stimulated with A23187.
  • Surface plasmon resonance spectroscopy to analyze beta2GPI binding kinetics and affinity.
  • Flow cytometry to assess the impact of beta2GPI on antibody binding to PMP surface markers.

Main Results:

  • Beta2GPI, activated protein C (APC), and annexin V bound to immobilized PMP, indicating exposed anionic phospholipids.
  • Beta2GPI binding to PMP was calcium-dependent and occurred with a dissociation constant (KD) of 1.7 x 10(-7) M.
  • Beta2GPI, but not APC or annexin V, reduced the binding of certain anti-GPIIb/IIIa monoclonal antibodies (mAbs) to PMP, while other markers remained unaffected.

Conclusions:

  • Beta2GPI specifically interacts with PMP and influences GPIIb/IIIa immunoreactivity.
  • Beta2GPI may act as a modulator of GPIIb/IIIa-dependent functions associated with PMP.
  • These findings highlight a novel role for beta2GPI in platelet microparticle biology.

More Related Videos

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.